We are live on ! Find out more
5VM

5AM Venture Management Portfolio holdings

AUM $360M
1-Year Est. Return 345.76%
This Fund
S&P 500
This Quarter Est. Return
+32.72%
1 Year Est. Return
+345.76%
3 Year Est. Return
+491.51%
5 Year Est. Return
+330.26%
10 Year Est. Return
–
AUM
$297M
AUM Growth
-$83.4M
Cap. Flow
-$79.7M
Cap. Flow %
-26.85%
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
–
Reduced
6
Closed
–

Top Buys

Rank Stock Value
1
FVAM
5:01 Acquisition Corp
FVAM
+$3.69M

Top Sells

Rank Stock Value
1
IDYA icon
IDEAYA Biosciences
IDYA
+$22.6M
2
APRE icon
Aprea Therapeutics
APRE
+$19.9M
3
ARVN icon
Arvinas
ARVN
+$17.2M
4
QTTB icon
Q32 Bio
QTTB
+$10.7M
5
AKUS
Akouos Inc
AKUS
+$9.16M

Sector Composition

Rank Sector Weight
1 Healthcare 98.75%
2 Financials 1.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AKUS
1
DELISTED
Akouos Inc
AKUS
$82M 27.62%
4,135,784
-470,000
-10% -$9.16M
QTTB icon
2
Q32 Bio
QTTB
$450M
$51.2M 17.25%
251,996
-55,555
-18% -$10.7M
ARVN icon
3
Arvinas
ARVN
$520M
$42.5M 14.3%
500,000
-500,000
-50% -$17.2M
CABA icon
4
Cabaletta Bio
CABA
$439M
$42.1M 14.17%
3,371,263
-298,000
-8% -$3.87M
IDYA icon
5
IDEAYA Biosciences
IDYA
$3.41B
$25.2M 8.48%
1,798,066
-1,665,000
-48% -$22.6M
SCPH
6
DELISTED
scPharmaceuticals
SCPH
$20.3M 6.83%
3,831,474
– –
CRNX icon
7
Crinetics Pharmaceuticals
CRNX
$8.89B
$19.2M 6.47%
1,362,286
– –
APRE icon
8
Aprea Therapeutics
APRE
$7.4M
$6.78M 2.28%
68,883
-41,750
-38% -$19.9M
CDTX
9
DELISTED
Cidara Therapeutics
CDTX
$4.01M 1.35%
100,326
– –
FVAM
10
DELISTED
5:01 Acquisition Corp
FVAM
$3.71M 1.25%
+365,126
New +$3.69M

Similar funds

LSC
Logan Stone Capital Chicago, Illinois $360M AUM 9.71% 1-Year Est. Return
WIP
WealthCare Investment Partners Portsmouth, Rhode Island $360M AUM 19.98% 1-Year Est. Return
RA
RR Advisors Dallas, Texas $360M AUM 28.52% 1-Year Est. Return
SWM
SK Wealth Management Providence, Rhode Island $360M AUM 14.81% 1-Year Est. Return
NC
Naman Capital Sao Paulo, Brazil $360M AUM 27.43% 1-Year Est. Return
MCM
Monimus Capital Management Woodbridge, New Jersey $361M AUM 21.17% 1-Year Est. Return
KLWA
Kelly Lawrence W & Associates Pasadens, California $360M AUM 16.9% 1-Year Est. Return
PWC
PYA Waltman Capital Knoxville, Tennessee $361M AUM 9.49% 1-Year Est. Return

5AM Venture Management's Q4 2020 Portfolio in Review

As of Q4 2020, 5AM Venture Management held 10 positions worth $297M, down 22% from $380M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

5AM Venture Management withdrew a net $79.7M in Q4 2020, reducing 6 holdings. Its largest reduction was IDEAYA Biosciences, cutting an estimated $22.6M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, down from 100% a quarter earlier, followed by Financials.

Against the trend, 5AM Venture Management opened a new position in 5:01 Acquisition Corp worth $3.71M.

  • 5AM Venture Management's largest Q4 2020 buy was 5:01 Acquisition Corp: 365,126 shares worth $3.71M.
  • 5AM Venture Management's biggest Q4 2020 reduction was IDEAYA Biosciences, cutting an estimated $22.6M.
  • 5AM Venture Management's ten largest holdings make up 100% of its $297M portfolio in Q4 2020.
  • 5AM Venture Management opened 1 new position and closed 0 in Q4 2020.
  • 5AM Venture Management's portfolio value fell 22% quarter-over-quarter to $297M.

Based on 5AM Venture Management's 13F filing for Q4 2020, filed 16 Feb 2021.